Copyright
©The Author(s) 2016.
World J Hepatol. Sep 8, 2016; 8(25): 1075-1086
Published online Sep 8, 2016. doi: 10.4254/wjh.v8.i25.1075
Published online Sep 8, 2016. doi: 10.4254/wjh.v8.i25.1075
Level of evidence | Description |
Type I | Evidence obtained at least from one well-designed, randomized, controlled1 trial or from a systematic review of randomized clinical studies |
Type II | II-1 evidence obtained from non-randomized, prospective, controlled1 studies |
II-2 evidence obtained from cohort observational studies2 or case-control studies, preferably multi-centric | |
II-3 evidence obtained from case series | |
Type III | Opinion of authorities on the subject matter based on expertise, expert committees, case reports, pathophysiological studies or basic science studies |
- Citation: Arab JP, Claro JC, Arancibia JP, Contreras J, Gómez F, Muñoz C, Nazal L, Roessler E, Wolff R, Arrese M, Benítez C. Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus. World J Hepatol 2016; 8(25): 1075-1086
- URL: https://www.wjgnet.com/1948-5182/full/v8/i25/1075.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i25.1075